BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18560230)

  • 1. Voriconazole-induced neuropathy.
    Aksoy F; Akdogan E; Aydin K; Yilmaz M; Altunayoglu V; Sozen EE; Omay SB; Koksal I
    Chemotherapy; 2008; 54(3):224-7. PubMed ID: 18560230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
    Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
    Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painful peripheral neuropathy associated with voriconazole use.
    Tsiodras S; Zafiropoulou R; Kanta E; Demponeras C; Karandreas N; Manesis EK
    Arch Neurol; 2005 Jan; 62(1):144-6. PubMed ID: 15642862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole-induced retinoid-like photosensitivity in children.
    Rubenstein M; Levy ML; Metry D
    Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole-induced photosensitivity.
    Malani AN; Aronoff DM
    Clin Med Res; 2008 Sep; 6(2):83-5. PubMed ID: 18801950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
    Boussaud V; Daudet N; Billaud EM; Lillo-Le Louet A; Chevalier P; Amrein C; Bergé MM; Guillemain R; Le Beller C
    J Heart Lung Transplant; 2008 Feb; 27(2):229-32. PubMed ID: 18267232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
    Porter CC; Carver AE; Albano EA
    Pediatr Blood Cancer; 2009 Feb; 52(2):298-300. PubMed ID: 18837430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M; Flowers SA; Rogers PD
    Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
    Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole in the treatment of fungal eye infections: a review of current literature.
    Hariprasad SM; Mieler WF; Lin TK; Sponsel WE; Graybill JR
    Br J Ophthalmol; 2008 Jul; 92(7):871-8. PubMed ID: 18577634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
    Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
    Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
    [No Abstract]   [Full Text] [Related]  

  • 13. Voriconazole in newborns.
    Kohli V; Taneja V; Sachdev P; Joshi R
    Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction.
    Frisch S; Askari SK; Beaty SR; Burkemper CN
    J Drugs Dermatol; 2010 May; 9(5):562-4. PubMed ID: 20480802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy in patients on long-term triazole antifungal therapy.
    Baxter CG; Marshall A; Roberts M; Felton TW; Denning DW
    J Antimicrob Chemother; 2011 Sep; 66(9):2136-9. PubMed ID: 21685202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    Supparatpinyo K; Schlamm HT
    Am J Trop Med Hyg; 2007 Aug; 77(2):350-3. PubMed ID: 17690411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsades de pointes associated with voriconazole use.
    Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
    Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
    Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
    Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
    Girmenia C; Pizzarelli G; Pozzi E; Cimino G; Gentile G; Martino P
    Haematologica; 2008 Jan; 93(1):159-60. PubMed ID: 18166809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.